 | • レポートコード：QY2112C03902 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はペフロキサシン·メタンスルホン酸の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ペフロキサシン·メタンスルホン酸の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（タブレット、カプセル、注射）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ペフロキサシン·メタンスルホン酸の世界市場概要 ・メーカー別の競争状況、市場シェア ・ペフロキサシン·メタンスルホン酸の種類別市場規模：タブレット、カプセル、注射 ・ペフロキサシン·メタンスルホン酸の用途別市場規模：病院薬局、小売薬局、その他 ・北米のペフロキサシン·メタンスルホン酸市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのペフロキサシン·メタンスルホン酸市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのペフロキサシン·メタンスルホン酸市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のペフロキサシン·メタンスルホン酸市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのペフロキサシン·メタンスルホン酸市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：AdvaCare Pharma、China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.、Ruiyang Pharmaceutical Co., Ltd.、Yichang Renfu Pharmaceutical Co., Ltd.、Shandong Lukang Pharmaceutical Group Saite Co., Ltd.、CommScope Pharmaceutical Co., Ltd.、Beijing Shuanglu Pharmaceutical Co., Ltd.、Beijing Sihuan Pharmaceutical Co., Ltd. ・ペフロキサシン·メタンスルホン酸のバリューチェーン・販売チャネル分析 ・ペフロキサシン·メタンスルホン酸の世界市場動向 |
Pefloxacin Mesylate is a quinolone antibacterial drug that can treat various infections caused by pefloxacin-sensitive bacteria, such as urinary tract infections and respiratory tract infections.
Market Analysis and Insights: Global Pefloxacin Mesylate Market
The global Pefloxacin Mesylate market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Pefloxacin Mesylate Scope and Segment
Pefloxacin Mesylate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pefloxacin Mesylate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Tablet
Capsule
Injection
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Company
AdvaCare Pharma
China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
Ruiyang Pharmaceutical Co., Ltd.
Yichang Renfu Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
CommScope Pharmaceutical Co., Ltd.
Beijing Shuanglu Pharmaceutical Co., Ltd.
Beijing Sihuan Pharmaceutical Co., Ltd.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Pefloxacin Mesylate Product Introduction
1.2 Market by Type
1.2.1 Global Pefloxacin Mesylate Market Size Growth Rate by Type
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Injection
1.3 Market by Application
1.3.1 Global Pefloxacin Mesylate Market Size Growth Rate by Application
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pefloxacin Mesylate Sales Estimates and Forecasts 2016-2027
2.2 Global Pefloxacin Mesylate Revenue Estimates and Forecasts 2016-2027
2.3 Global Pefloxacin Mesylate Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Pefloxacin Mesylate Regions by Sales
2.4.1 Global Top Pefloxacin Mesylate Regions by Sales (2016-2021)
2.4.2 Global Top Pefloxacin Mesylate Regions by Sales (2022-2027)
2.5 Global Top Pefloxacin Mesylate Regions by Revenue
2.5.1 Global Top Pefloxacin Mesylate Regions by Revenue (2016-2021)
2.5.2 Global Top Pefloxacin Mesylate Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pefloxacin Mesylate Sales by Manufacturers
3.1.1 Global Top Pefloxacin Mesylate Manufacturers by Sales (2016-2021)
3.1.2 Global Top Pefloxacin Mesylate Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Pefloxacin Mesylate Sales in 2020
3.2 Global Pefloxacin Mesylate Revenue by Manufacturers
3.2.1 Global Top Pefloxacin Mesylate Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Pefloxacin Mesylate Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Pefloxacin Mesylate Revenue in 2020
3.3 Global Pefloxacin Mesylate Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pefloxacin Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pefloxacin Mesylate Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pefloxacin Mesylate Sales by Type
4.1.1 Global Pefloxacin Mesylate Historical Sales by Type (2016-2021)
4.1.2 Global Pefloxacin Mesylate Forecasted Sales by Type (2022-2027)
4.1.3 Global Pefloxacin Mesylate Sales Market Share by Type (2016-2027)
4.2 Global Pefloxacin Mesylate Revenue by Type
4.2.1 Global Pefloxacin Mesylate Historical Revenue by Type (2016-2021)
4.2.2 Global Pefloxacin Mesylate Forecasted Revenue by Type (2022-2027)
4.2.3 Global Pefloxacin Mesylate Revenue Market Share by Type (2016-2027)
4.3 Global Pefloxacin Mesylate Price by Type
4.3.1 Global Pefloxacin Mesylate Price by Type (2016-2021)
4.3.2 Global Pefloxacin Mesylate Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Pefloxacin Mesylate Sales by Application
5.1.1 Global Pefloxacin Mesylate Historical Sales by Application (2016-2021)
5.1.2 Global Pefloxacin Mesylate Forecasted Sales by Application (2022-2027)
5.1.3 Global Pefloxacin Mesylate Sales Market Share by Application (2016-2027)
5.2 Global Pefloxacin Mesylate Revenue by Application
5.2.1 Global Pefloxacin Mesylate Historical Revenue by Application (2016-2021)
5.2.2 Global Pefloxacin Mesylate Forecasted Revenue by Application (2022-2027)
5.2.3 Global Pefloxacin Mesylate Revenue Market Share by Application (2016-2027)
5.3 Global Pefloxacin Mesylate Price by Application
5.3.1 Global Pefloxacin Mesylate Price by Application (2016-2021)
5.3.2 Global Pefloxacin Mesylate Price Forecast by Application (2022-2027)
6 North America
6.1 North America Pefloxacin Mesylate Market Size by Type
6.1.1 North America Pefloxacin Mesylate Sales by Type (2016-2027)
6.1.2 North America Pefloxacin Mesylate Revenue by Type (2016-2027)
6.2 North America Pefloxacin Mesylate Market Size by Application
6.2.1 North America Pefloxacin Mesylate Sales by Application (2016-2027)
6.2.2 North America Pefloxacin Mesylate Revenue by Application (2016-2027)
6.3 North America Pefloxacin Mesylate Market Size by Country
6.3.1 North America Pefloxacin Mesylate Sales by Country (2016-2027)
6.3.2 North America Pefloxacin Mesylate Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pefloxacin Mesylate Market Size by Type
7.1.1 Europe Pefloxacin Mesylate Sales by Type (2016-2027)
7.1.2 Europe Pefloxacin Mesylate Revenue by Type (2016-2027)
7.2 Europe Pefloxacin Mesylate Market Size by Application
7.2.1 Europe Pefloxacin Mesylate Sales by Application (2016-2027)
7.2.2 Europe Pefloxacin Mesylate Revenue by Application (2016-2027)
7.3 Europe Pefloxacin Mesylate Market Size by Country
7.3.1 Europe Pefloxacin Mesylate Sales by Country (2016-2027)
7.3.2 Europe Pefloxacin Mesylate Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pefloxacin Mesylate Market Size by Type
8.1.1 Asia Pacific Pefloxacin Mesylate Sales by Type (2016-2027)
8.1.2 Asia Pacific Pefloxacin Mesylate Revenue by Type (2016-2027)
8.2 Asia Pacific Pefloxacin Mesylate Market Size by Application
8.2.1 Asia Pacific Pefloxacin Mesylate Sales by Application (2016-2027)
8.2.2 Asia Pacific Pefloxacin Mesylate Revenue by Application (2016-2027)
8.3 Asia Pacific Pefloxacin Mesylate Market Size by Region
8.3.1 Asia Pacific Pefloxacin Mesylate Sales by Region (2016-2027)
8.3.2 Asia Pacific Pefloxacin Mesylate Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pefloxacin Mesylate Market Size by Type
9.1.1 Latin America Pefloxacin Mesylate Sales by Type (2016-2027)
9.1.2 Latin America Pefloxacin Mesylate Revenue by Type (2016-2027)
9.2 Latin America Pefloxacin Mesylate Market Size by Application
9.2.1 Latin America Pefloxacin Mesylate Sales by Application (2016-2027)
9.2.2 Latin America Pefloxacin Mesylate Revenue by Application (2016-2027)
9.3 Latin America Pefloxacin Mesylate Market Size by Country
9.3.1 Latin America Pefloxacin Mesylate Sales by Country (2016-2027)
9.3.2 Latin America Pefloxacin Mesylate Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Pefloxacin Mesylate Market Size by Type
10.1.1 Middle East and Africa Pefloxacin Mesylate Sales by Type (2016-2027)
10.1.2 Middle East and Africa Pefloxacin Mesylate Revenue by Type (2016-2027)
10.2 Middle East and Africa Pefloxacin Mesylate Market Size by Application
10.2.1 Middle East and Africa Pefloxacin Mesylate Sales by Application (2016-2027)
10.2.2 Middle East and Africa Pefloxacin Mesylate Revenue by Application (2016-2027)
10.3 Middle East and Africa Pefloxacin Mesylate Market Size by Country
10.3.1 Middle East and Africa Pefloxacin Mesylate Sales by Country (2016-2027)
10.3.2 Middle East and Africa Pefloxacin Mesylate Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AdvaCare Pharma
11.1.1 AdvaCare Pharma Corporation Information
11.1.2 AdvaCare Pharma Overview
11.1.3 AdvaCare Pharma Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AdvaCare Pharma Pefloxacin Mesylate Product Description
11.1.5 AdvaCare Pharma Recent Developments
11.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
11.2.1 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Corporation Information
11.2.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Overview
11.2.3 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Product Description
11.2.5 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Developments
11.3 Ruiyang Pharmaceutical Co., Ltd.
11.3.1 Ruiyang Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Ruiyang Pharmaceutical Co., Ltd. Overview
11.3.3 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Description
11.3.5 Ruiyang Pharmaceutical Co., Ltd. Recent Developments
11.4 Yichang Renfu Pharmaceutical Co., Ltd.
11.4.1 Yichang Renfu Pharmaceutical Co., Ltd. Corporation Information
11.4.2 Yichang Renfu Pharmaceutical Co., Ltd. Overview
11.4.3 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Description
11.4.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
11.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
11.5.1 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Corporation Information
11.5.2 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Overview
11.5.3 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Product Description
11.5.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Developments
11.6 CommScope Pharmaceutical Co., Ltd.
11.6.1 CommScope Pharmaceutical Co., Ltd. Corporation Information
11.6.2 CommScope Pharmaceutical Co., Ltd. Overview
11.6.3 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Description
11.6.5 CommScope Pharmaceutical Co., Ltd. Recent Developments
11.7 Beijing Shuanglu Pharmaceutical Co., Ltd.
11.7.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Corporation Information
11.7.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Overview
11.7.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Description
11.7.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
11.8 Beijing Sihuan Pharmaceutical Co., Ltd.
11.8.1 Beijing Sihuan Pharmaceutical Co., Ltd. Corporation Information
11.8.2 Beijing Sihuan Pharmaceutical Co., Ltd. Overview
11.8.3 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Description
11.8.5 Beijing Sihuan Pharmaceutical Co., Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pefloxacin Mesylate Value Chain Analysis
12.2 Pefloxacin Mesylate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pefloxacin Mesylate Production Mode & Process
12.4 Pefloxacin Mesylate Sales and Marketing
12.4.1 Pefloxacin Mesylate Sales Channels
12.4.2 Pefloxacin Mesylate Distributors
12.5 Pefloxacin Mesylate Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pefloxacin Mesylate Industry Trends
13.2 Pefloxacin Mesylate Market Drivers
13.3 Pefloxacin Mesylate Market Challenges
13.4 Pefloxacin Mesylate Market Restraints
14 Key Findings in The Global Pefloxacin Mesylate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Pefloxacin Mesylate Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Capsule
Table 4. Major Manufacturers of Injection
Table 5. Global Pefloxacin Mesylate Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Pefloxacin Mesylate Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Pefloxacin Mesylate Sales by Region (2016-2021) & (K Units)
Table 8. Global Pefloxacin Mesylate Sales Market Share by Region (2016-2021)
Table 9. Global Pefloxacin Mesylate Sales by Region (2022-2027) & (K Units)
Table 10. Global Pefloxacin Mesylate Sales Market Share by Region (2022-2027)
Table 11. Global Pefloxacin Mesylate Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Pefloxacin Mesylate Revenue Market Share by Region (2016-2021)
Table 13. Global Pefloxacin Mesylate Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Pefloxacin Mesylate Revenue Market Share by Region (2022-2027)
Table 15. Global Pefloxacin Mesylate Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Pefloxacin Mesylate Sales Share by Manufacturers (2016-2021)
Table 17. Global Pefloxacin Mesylate Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Pefloxacin Mesylate Revenue Share by Manufacturers (2016-2021)
Table 19. Pefloxacin Mesylate Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Pefloxacin Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Pefloxacin Mesylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pefloxacin Mesylate as of 2020)
Table 22. Pefloxacin Mesylate Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pefloxacin Mesylate Product Offered
Table 24. Date of Manufacturers Enter into Pefloxacin Mesylate Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pefloxacin Mesylate Sales by Type (2016-2021) & (K Units)
Table 27. Global Pefloxacin Mesylate Sales by Type (2022-2027) & (K Units)
Table 28. Global Pefloxacin Mesylate Sales Share by Type (2016-2021)
Table 29. Global Pefloxacin Mesylate Sales Share by Type (2022-2027)
Table 30. Global Pefloxacin Mesylate Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Pefloxacin Mesylate Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Pefloxacin Mesylate Revenue Share by Type (2016-2021)
Table 33. Global Pefloxacin Mesylate Revenue Share by Type (2022-2027)
Table 34. Pefloxacin Mesylate Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Pefloxacin Mesylate Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Pefloxacin Mesylate Sales by Application (2016-2021) & (K Units)
Table 37. Global Pefloxacin Mesylate Sales by Application (2022-2027) & (K Units)
Table 38. Global Pefloxacin Mesylate Sales Share by Application (2016-2021)
Table 39. Global Pefloxacin Mesylate Sales Share by Application (2022-2027)
Table 40. Global Pefloxacin Mesylate Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Pefloxacin Mesylate Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Pefloxacin Mesylate Revenue Share by Application (2016-2021)
Table 43. Global Pefloxacin Mesylate Revenue Share by Application (2022-2027)
Table 44. Pefloxacin Mesylate Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Pefloxacin Mesylate Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Pefloxacin Mesylate Sales by Type (2016-2021) & (K Units)
Table 47. North America Pefloxacin Mesylate Sales by Type (2022-2027) & (K Units)
Table 48. North America Pefloxacin Mesylate Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Pefloxacin Mesylate Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Pefloxacin Mesylate Sales by Application (2016-2021) & (K Units)
Table 51. North America Pefloxacin Mesylate Sales by Application (2022-2027) & (K Units)
Table 52. North America Pefloxacin Mesylate Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Pefloxacin Mesylate Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Pefloxacin Mesylate Sales by Country (2016-2021) & (K Units)
Table 55. North America Pefloxacin Mesylate Sales by Country (2022-2027) & (K Units)
Table 56. North America Pefloxacin Mesylate Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Pefloxacin Mesylate Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Pefloxacin Mesylate Sales by Type (2016-2021) & (K Units)
Table 59. Europe Pefloxacin Mesylate Sales by Type (2022-2027) & (K Units)
Table 60. Europe Pefloxacin Mesylate Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Pefloxacin Mesylate Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Pefloxacin Mesylate Sales by Application (2016-2021) & (K Units)
Table 63. Europe Pefloxacin Mesylate Sales by Application (2022-2027) & (K Units)
Table 64. Europe Pefloxacin Mesylate Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Pefloxacin Mesylate Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Pefloxacin Mesylate Sales by Country (2016-2021) & (K Units)
Table 67. Europe Pefloxacin Mesylate Sales by Country (2022-2027) & (K Units)
Table 68. Europe Pefloxacin Mesylate Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Pefloxacin Mesylate Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Pefloxacin Mesylate Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Pefloxacin Mesylate Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Pefloxacin Mesylate Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Pefloxacin Mesylate Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Pefloxacin Mesylate Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Pefloxacin Mesylate Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Pefloxacin Mesylate Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Pefloxacin Mesylate Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Pefloxacin Mesylate Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Pefloxacin Mesylate Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Pefloxacin Mesylate Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Pefloxacin Mesylate Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Pefloxacin Mesylate Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Pefloxacin Mesylate Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Pefloxacin Mesylate Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Pefloxacin Mesylate Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Pefloxacin Mesylate Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Pefloxacin Mesylate Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Pefloxacin Mesylate Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Pefloxacin Mesylate Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Pefloxacin Mesylate Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Pefloxacin Mesylate Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Pefloxacin Mesylate Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Pefloxacin Mesylate Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Pefloxacin Mesylate Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Pefloxacin Mesylate Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Pefloxacin Mesylate Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Pefloxacin Mesylate Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Pefloxacin Mesylate Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Pefloxacin Mesylate Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Pefloxacin Mesylate Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Pefloxacin Mesylate Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Pefloxacin Mesylate Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Pefloxacin Mesylate Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Pefloxacin Mesylate Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Pefloxacin Mesylate Revenue by Country (2022-2027) & (US$ Million)
Table 106. AdvaCare Pharma Corporation Information
Table 107. AdvaCare Pharma Description and Major Businesses
Table 108. AdvaCare Pharma Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. AdvaCare Pharma Pefloxacin Mesylate Product
Table 110. AdvaCare Pharma Recent Developments
Table 111. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Corporation Information
Table 112. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Description and Major Businesses
Table 113. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Product
Table 115. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Developments
Table 116. Ruiyang Pharmaceutical Co., Ltd. Corporation Information
Table 117. Ruiyang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 118. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
Table 120. Ruiyang Pharmaceutical Co., Ltd. Recent Developments
Table 121. Yichang Renfu Pharmaceutical Co., Ltd. Corporation Information
Table 122. Yichang Renfu Pharmaceutical Co., Ltd. Description and Major Businesses
Table 123. Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
Table 125. Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
Table 126. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Corporation Information
Table 127. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Description and Major Businesses
Table 128. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Product
Table 130. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Developments
Table 131. CommScope Pharmaceutical Co., Ltd. Corporation Information
Table 132. CommScope Pharmaceutical Co., Ltd. Description and Major Businesses
Table 133. CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
Table 135. CommScope Pharmaceutical Co., Ltd. Recent Developments
Table 136. Beijing Shuanglu Pharmaceutical Co., Ltd. Corporation Information
Table 137. Beijing Shuanglu Pharmaceutical Co., Ltd. Description and Major Businesses
Table 138. Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
Table 140. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
Table 141. Beijing Sihuan Pharmaceutical Co., Ltd. Corporation Information
Table 142. Beijing Sihuan Pharmaceutical Co., Ltd. Description and Major Businesses
Table 143. Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product
Table 145. Beijing Sihuan Pharmaceutical Co., Ltd. Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Pefloxacin Mesylate Distributors List
Table 149. Pefloxacin Mesylate Customers List
Table 150. Pefloxacin Mesylate Market Trends
Table 151. Pefloxacin Mesylate Market Drivers
Table 152. Pefloxacin Mesylate Market Challenges
Table 153. Pefloxacin Mesylate Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Pefloxacin Mesylate Product Picture
Figure 2. Global Pefloxacin Mesylate Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Pefloxacin Mesylate Market Share by Application in 2020 & 2027
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Others
Figure 10. Pefloxacin Mesylate Report Years Considered
Figure 11. Global Pefloxacin Mesylate Sales 2016-2027 (K Units)
Figure 12. Global Pefloxacin Mesylate Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pefloxacin Mesylate Revenue 2016-2027 (US$ Million)
Figure 14. Global Pefloxacin Mesylate Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Pefloxacin Mesylate Sales Market Share by Region (2016-2021)
Figure 16. Global Pefloxacin Mesylate Sales Market Share by Region (2022-2027)
Figure 17. North America Pefloxacin Mesylate Sales YoY (2016-2027) & (K Units)
Figure 18. North America Pefloxacin Mesylate Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Pefloxacin Mesylate Sales YoY (2016-2027) & (K Units)
Figure 20. Europe Pefloxacin Mesylate Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Pefloxacin Mesylate Sales YoY (2016-2027) & (K Units)
Figure 22. Asia-Pacific Pefloxacin Mesylate Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Pefloxacin Mesylate Sales YoY (2016-2027) & (K Units)
Figure 24. Latin America Pefloxacin Mesylate Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Pefloxacin Mesylate Sales YoY (2016-2027) & (K Units)
Figure 26. Middle East & Africa Pefloxacin Mesylate Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Pefloxacin Mesylate Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Pefloxacin Mesylate Revenue in 2020
Figure 29. Pefloxacin Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Pefloxacin Mesylate Sales Market Share by Type (2016-2027)
Figure 31. Global Pefloxacin Mesylate Revenue Market Share by Type (2016-2027)
Figure 32. Global Pefloxacin Mesylate Sales Market Share by Application (2016-2027)
Figure 33. Global Pefloxacin Mesylate Revenue Market Share by Application (2016-2027)
Figure 34. North America Pefloxacin Mesylate Sales Market Share by Type (2016-2027)
Figure 35. North America Pefloxacin Mesylate Revenue Market Share by Type (2016-2027)
Figure 36. North America Pefloxacin Mesylate Sales Market Share by Application (2016-2027)
Figure 37. North America Pefloxacin Mesylate Revenue Market Share by Application (2016-2027)
Figure 38. North America Pefloxacin Mesylate Sales Share by Country (2016-2027)
Figure 39. North America Pefloxacin Mesylate Revenue Share by Country (2016-2027)
Figure 40. United States Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Pefloxacin Mesylate Sales Market Share by Type (2016-2027)
Figure 43. Europe Pefloxacin Mesylate Revenue Market Share by Type (2016-2027)
Figure 44. Europe Pefloxacin Mesylate Sales Market Share by Application (2016-2027)
Figure 45. Europe Pefloxacin Mesylate Revenue Market Share by Application (2016-2027)
Figure 46. Europe Pefloxacin Mesylate Sales Share by Country (2016-2027)
Figure 47. Europe Pefloxacin Mesylate Revenue Share by Country (2016-2027)
Figure 48. Germany Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 49. France Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Pefloxacin Mesylate Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Pefloxacin Mesylate Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Pefloxacin Mesylate Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Pefloxacin Mesylate Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Pefloxacin Mesylate Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Pefloxacin Mesylate Revenue Share by Region (2016-2027)
Figure 59. China Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 62. India Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 64. China Taiwan Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Pefloxacin Mesylate Sales Market Share by Type (2016-2027)
Figure 69. Latin America Pefloxacin Mesylate Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Pefloxacin Mesylate Sales Market Share by Application (2016-2027)
Figure 71. Latin America Pefloxacin Mesylate Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Pefloxacin Mesylate Sales Share by Country (2016-2027)
Figure 73. Latin America Pefloxacin Mesylate Revenue Share by Country (2016-2027)
Figure 74. Mexico Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 77. Colombia Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Pefloxacin Mesylate Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Pefloxacin Mesylate Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Pefloxacin Mesylate Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Pefloxacin Mesylate Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Pefloxacin Mesylate Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Pefloxacin Mesylate Revenue Share by Country (2016-2027)
Figure 84. Turkey Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 86. UAE Pefloxacin Mesylate Revenue (2016-2027) & (US$ Million)
Figure 87. Pefloxacin Mesylate Value Chain
Figure 88. Pefloxacin Mesylate Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
オシメルチニブメシル酸塩APIのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Osimertinib Mesylate API Market The global Osimertinib Mesylate API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Osimertinib Mesylate API Scope and Segm…- 薬局調剤システムのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Pharmacy Dispensing System Market The global Pharmacy Dispensing System market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Pharmacy Dispensing System Scope an…
- 医薬品自動調剤システムのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Pharmacy Automated Dispensing System Market The global Pharmacy Automated Dispensing System market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Pharmacy Automa…
- 医薬品バッグのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Pharmacy Bags Market The global Pharmacy Bags market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Pharmacy Bags Scope and Segment Pharmacy Bags market is segme…
- 医薬品用フード＆封じ込め装置のグローバル市場インサイト・予測（～2027年） Pharmacy Hoods & Containment equipment includes a variety of workstations designed for non-hazardous and hazardous drug preparation meeting USP 797 & 800 PEC requirements. Products include Compounding Pharmacy Isolators, BioSafety Cabinets & Laminar Flow Hoods. Market Analysis and Insights: Global P…